查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
雨生紅球藻全球市場 - 2022-2029
市場調查報告書
商品編碼
1169028

雨生紅球藻全球市場 - 2022-2029

Global Haematococcus Pluvialis Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 97 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

雨生紅球藻市場預計在預測期內（2022-2029 年）以 10.23% 的複合年增長率增長。

雨生紅球藻廣泛用於生產高價值最終產品的行業，例如食品和飲料、膳食補充劑、藥品、油漆和顏料、肥料和燃料。 雨生紅球藻含有脂質、藻類蛋白質、水膠體和其他成分，使其在製造最終產品時非常有用且備受追捧。 各種類型的微藻和海藻，包括藍綠藻 (BGA)、紅藻和褐藻，被用於製造釋放有益營養素的實用產品。 綠藻雨生紅球藻數量豐富、耐寒且價格低廉，在世界範圍內經常用於生物製品。 它用於生產用於治療糖尿病、多發性硬化症和癌症的藥物、維生素、疫苗、膳食補充劑和其他營養素。 雨生紅球藻在養殖魚類和其他養殖牲畜生產中的應用擴大了市場。

市場動態：膳食補充劑中對天然蝦青素的需求不斷增長推動市場擴張

蝦青素的一個潛在來源是雨生紅球藻微藻。 它是一種類胡蘿蔔素，在紅色生長階段會積累顏色並起到抗氧化劑的作用。 藻類來源的蝦青素經常被用作藥物，因為它具有增強的抗氧化活性和潛在的治療效果。 最近的研究證實，這種鮮紅色的類胡蘿蔔素可以清除自由基並減少氧化應激，表明這種作用有益於心血管健康、體力消耗後的恢復以及皮膚和關節健康。它是

另一方面，由於慢性病的增加和人們生活方式的改變，全球範圍內保健食品和營養補充劑的消費量顯著增加。 這是影響市場擴張的最重要因素之一。 雨生紅球藻也經常用於去除或轉化廢水中的污染物，例如營養物、重金屬和異生素。

然而，高生產成本和氣候對雨生紅球藻的影響預計將減緩市場增長速度。 此外，食用基於藻類的處方藥產品（如小球藻、太陽能微藻和螺旋藻）會導致胃腸道、腹部和噁心症狀。 該問題將限制雨生紅球藻整體市場的拓展。 此外，在整個預測期內，由於新興國家的研發活動和意識低下，雨生紅球藻市場將面臨挑戰。

市場細分：蝦青素大宗成品細分市場全球雨生紅球藻佔比最高

許多微藻類、酵母菌和細菌都含有類胡蘿蔔素色素蝦青素。 雨生紅球藻是一種綠色微藻，在壓力下（例如營養缺乏或暴露於強光下）會產生大量蝦青素。 當紅球藻細胞受損時，釋放的蝦青素可用作營養補充劑、功能性食品和飲料、化妝品和藥物的成分。

另一方面，蝦青素是一種天然存在的類胡蘿蔔素色素，作為葉黃素的一員，市場有望擴大。 它存在於藻類和水生生物中，例如鮭魚、鱒魚、磷蝦、蝦和龍蝦。 蝦青素賦予這些生物粉紅色和紅色。 雨生紅球藻是一種微藻，是蝦青素的主要商業來源。

地理滲透：北美將成為預測期內的主導區域

北美預計在預測期內會增長。 北美的很大一部分主要是由於消費者對化學產品的負面影響的認識不斷提高以及對天然食品補充劑的需求不斷增加。 此外，預計不同組織開展的幾項宣傳活動將增加該地區的市場份額。 例如，天然藻類蝦青素協會 (NAXA) 致力於傳播有關蝦青素消費的知識。 雨生紅球藻在美國和加拿大也被允許用作膳食補充劑的成分，這是影響北美物種擴張的另一個重要因素。

另一方面，由於健康意識的提高、食品飲料和保健品行業的擴張、對個人護理產品的巨大需求以及高投資，預計亞太地區在預測期內將以最快的複合年增長率增長在藻類生產中。預期。 此外，亞洲國家政府對藻類生產的支持不斷增加，為該地區的各種市場參與者提供了巨大的機會。

內容

第1章調查方法及範圍

  • 調查方法
  • 市場範圍

第2章主要趨勢與發展

第 3 章執行摘要

  • 按類型細分的市場
  • 按應用劃分的市場細分
  • 按地區劃分的市場細分

第4章市場動態

  • 市場影響因素
    • 司機
    • 約束因素
    • 商機
  • 影響分析

第5章行業分析

  • 波特的五力分析
  • 價值鏈分析
  • 專利分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措

第 7 章按類型

  • 蝦青素原料
  • 蝦青素活性成分成品

第 8 章應用

  • 食物和飲料
  • 營養保健品
  • 醫藥
  • 化妝品
  • 動物飼料

第9章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第10章競爭格局

  • 競爭場景
  • 競爭戰略分析
  • 市場情況/份額分析
  • 併購分析

第11章公司簡介

  • 氰技術公司
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • E.I.D. Parry
  • BlueBioTech
  • Algae to Omega
  • Tianjin Norland Biotech
  • AlgaeCan Biotech
  • AstaReal AB
  • Yunnan Alphy Biotech
  • Pond Technologies
  • Fenchem

第12章 DataM

簡介目錄
Product Code: DMFB6038

Market Overview

Haematococcus Pluvialis Market was valued at USD YY million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of 10.23% during the forecast period (2022-2029)

Haematococcus Pluvialis is used in a wide range of industries to produce high-value end products, including food and drink, nutraceuticals, pharmaceuticals, paints and colorants, fertilizer, and fuel. Haematococcus Pluvialis is useful and highly demanded in making finished products because of its lipids, algal proteins, hydrocolloids, and other components. The various types of microalgae or seaweed, including blue-green algae (BGA), red algae, and brown algae, are used to make practical products that are bursting with beneficial nutrients. Because it is plentiful, hardy, and affordable, green haematococcus pluvialis is frequently used in biological medications worldwide. For the treatment of diabetes, multiple sclerosis, and cancer, they are used in the production of pharmaceuticals, vitamins, vaccines, nutraceuticals, and other nutrients. Adopting haematococcus pluvialis to produce fish for cultivation and other livestock for aquaculture varieties is growing the market.

Market Dynamics: Growing demand for natural astaxanthin in nutraceuticals drives market expansion

A potential source of astaxanthin is the microalga haematococcus pluvialis. It is a carotenoid that accumulates in color and is an antioxidant during the red growth phase. Due to its increased antioxidant activity and therapeutic potential, astaxanthin derived from algae is frequently used in pharmaceutical applications. Recent studies have confirmed the vibrant red carotenoid's capacity to snuff out free radicals and lessen oxidative stress, correlating this action with benefits for cardiovascular health, recovery from physical exertion, and skin and joint health.

On the other hand, the consumption of healthy food items and dietary supplements has significantly increased worldwide due to the rise in chronic disease prevalence and people's changing lifestyles. One of the most important elements affecting market expansion is this. In addition, haematococcus pluvialis is frequently used to remove and transform pollutants from wastewater, including nutrients, heavy metals, and xenobiotics.

However, the market's growth rate will be slowed by the high production cost and climate's effect on haematococcus pluvialision. Furthermore, the consumption of algae-based prescription medicine products like chlorella, sun microalgae, and spirulina brought gastrointestinal, abdominal, and nauseous symptoms. This issue will limit the market's overall expansion for haematococcus pluvialis. Throughout the forecast period, the haematococcus pluvialis market will also face difficulties due to a lack of R&D activities in developing nations and awareness.

Market Segmentation: Astaxanthin bulk finished products segment accounted for the highest share in global global haematococcus pluvialis

Numerous microalgae, yeast, and bacteria contain the carotenoid pigment astaxanthin. A green microalga called haematococcus pluvialis produces a lot of astaxanthin when under stress, like when it's starved of nutrients or exposed to intense light. The released astaxanthin can be used as an ingredient in dietary supplements, functional foods and beverages, cosmetics, and pharmaceuticals when haematococcin cells are damaged.

On the other hand, astaxanthin is expected to grow in the market as a carotenoid pigment found naturally and is a member of the xanthophyll family. Algae and aquatic creatures like salmon, trout, krill, shrimp, and lobster contain it. These organisms are pink or red because of astaxanthin. The microalga Haematococcus Pluvialis is the primary commercial source of astaxanthin.

Geographical Penetration: The North America is the dominating region during the forecast period

North America is expected to grow during the forecast period. A significant portion of North America is primarily attributed to rising consumer awareness of the negative effects of chemical products and rising demand for natural food supplements. Additionally, several awareness campaigns by different organizations are predicted to increase the regional market share. For instance, the Natural Algae Astaxanthin Association (NAXA) is committed to spreading knowledge about the consumption of astaxanthin. The fact that haematococcus pluvialis algae are permitted for use as a component in dietary supplements in the United States and Canada is another important factor influencing the species' expansion in North America.

On the other hand, due to rising health consciousness, the expansion of the food and beverage and nutraceutical industries, the enormous demand for personal care products, and high investment in algae production, the Asia Pacific region is anticipated to grow at the fastest CAGR during the forecast period. Additionally, the growing government support for algae production in Asian nations presents significant opportunities for the region's various market participants.

Competitive Landscape:

There are several established participants in the industry and local manufacturers; hence, the market is fragmented. Some major key players include Cyanotech Corporation, E.I.D. Parry, BlueBioTech, Algae to Omega, Tianjin Norland Biotech, AlgaeCan Biotech, AstaReal AB, Yunnan Alphy Biotech, Pond Technologies, Fenchem, and BDI-BioLife Science. During the forecast period, these are some key factors anticipated to propel the growth of the global haematococcus pluvialis market. For instance, in 2021, Lycored introduced in Branchburg, New Jersey, an oleoresin made from haematococcus pluvialis algae for soft gels and a microencapsulated starch beadlet, cold water dispersible microencapsulated solution for beverages, and dry mixes.

On the other hand, On July 27th, 2021 AstaReal, has launched NOVASTA, a pet food and feed ingredient rich in antioxidants, into the European market. On the other hand, on 2nd October 2020, Erber Group was purchased by Royal DSM for an enterprise value of €980 million. Royal DSM is a global science-based nutrition, health, and sustainable living company.

COVID-19 Impact: Positive impact on the global haematococcus pluvialis market

The abrupt COVID-19 pandemic outbreak prompted the implementation of strict lockdown regulations across many countries. In addition to dealing with the COVID-19 pandemic, the world is battling other health crises. The COVID-19 pandemic has had a significant impact on the haematococcus pluvialis market, emphasizing the significance of consumers' worldwide adopting secure, wholesome, and nutritive eating practices. A significant factor anticipated to fuel market growth is the preference of more health-conscious consumers for natural food coloring agents that have fewer side effects than other chemical products. As a result, the demand for the haematococcus pluvialis market has not affected by the universal pandemic.

The global haematococcus pluvialis market report would provide an access to approximately 53 market data tables, 44 figures and 97 pages.

Table of Contents

1. Scope and Methodology

  • 1.1. Research Methodology
  • 1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market impacting factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
  • 4.2. Impact analysis

5. Industry Analysis

  • 5.1. Porter's five forces analysis
  • 5.2. Value chain analysis
  • 5.3. Patent Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Type
    • 7.1.2. Market attractiveness index, By Type
  • 7.2. Astaxanthin Ingredients *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 7.3. Astaxanthin Bulk Finished Products

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Application
    • 8.1.2. Market attractiveness index, By Application
  • 8.2. Food and Beverage *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
  • 8.3. Nutraceuticals
  • 8.4. Pharmaceuticals
  • 8.5. Cosmetics
  • 8.6. Animal Feeds

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key region-specific dynamics
    • 9.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 9.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 9.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Rest of South America
  • 9.4. Europe
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 9.4.5.1. Germany
      • 9.4.5.2. U.K.
      • 9.4.5.3. France
      • 9.4.5.4. Spain
      • 9.4.5.5. Italy
      • 9.4.5.6. Rest of Europe
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 9.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Type
    • 9.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application

10. Competitive Landscape

  • 10.1. Competitive scenario
  • 10.2. Competitor strategy analysis
  • 10.3. Market positioning/share analysis
  • 10.4. Mergers and acquisitions analysis

11. Company Profiles

  • 11.1. Cyanotech Corporation *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. E.I.D. Parry
  • 11.3. BlueBioTech
  • 11.4. Algae to Omega
  • 11.5. Tianjin Norland Biotech
  • 11.6. AlgaeCan Biotech
  • 11.7. AstaReal AB
  • 11.8. Yunnan Alphy Biotech
  • 11.9. Pond Technologies
  • 11.10. Fenchem
  • List not Exhaustive*

12. DataM

  • 12.1. Appendix
  • 12.2. About us and services
  • 12.3. Contact us